Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: Detrol LA In Men With Overactive Bladder. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Detrol LA in men with overactive bladder, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Detrol LA (tolterodine tartrate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Overactive Bladder (OAB) | Phase 4 | Status: COMPLETED